Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2017

01-05-2017 | Original Article

Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population

Authors: T.-d. Li, J.-j. Li, X. Huang, H. Wang, X.-y. Guo, S.-x. Ge, J. Zhang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2017

Login to get access

Abstract

Recurrent human cytomegalovirus (HCMV) infection during pregnancy could lead to congenital HCMV infection and permanent sequelae. However, knowledge regarding the risk factors associated with recurrent HCMV infection is limited. In the present study, 1,659 paired serum samples from the natural population were collected in Guangxi Province, China, from 2003 to 2004 with a 1-year interval. The serum anti-pp150 titre was quantitatively determined using a homemade recombinant pp150-based ELISA, and the IgG titre that increased at least 4-fold was defined as a recurrent infection. The HCMV seroprevalence was above 98.6% (1,636/1,659) in Guangxi in 2003, and the infection rate during the 1-year follow-up was approximately 10% (171/1,659). The seronegative population has the highest infection risk, while the risk of recurrent infection in the seropositive population was negatively correlated with the baseline anti-pp150 titre. With a cutoff of 1:80 (the baseline anti-pp150 IgG titre), the sensitivity and specificity were 73.1% (125/171) and 85.7% (1,275/1,488) respectively, and the relative risk of infection in the high-risk group compared to the low-risk group was 10.6 (95% CI: 7.7–14.6). In conclusion, the baseline anti-pp150 IgG was negatively correlated with the risk of HCMV infection and could be an excellent predictor of HCMV infection in HCMV seropositive populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grosse SD, Ross DS, Dollard SC (2008) Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment. J Clin Virol 41(2):57–62CrossRefPubMed Grosse SD, Ross DS, Dollard SC (2008) Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment. J Clin Virol 41(2):57–62CrossRefPubMed
2.
go back to reference Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26(1):86–102CrossRefPubMedPubMedCentral Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26(1):86–102CrossRefPubMedPubMedCentral
3.
go back to reference Yamamoto AY, Mussi-Pinhata MM, Isaac MD, Amaral FR, Carvalheiro CG, Aragon DC, Manfredi AKD, Boppana SB, Britt WJ (2011) Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J 30(12):1043–1046CrossRefPubMedPubMedCentral Yamamoto AY, Mussi-Pinhata MM, Isaac MD, Amaral FR, Carvalheiro CG, Aragon DC, Manfredi AKD, Boppana SB, Britt WJ (2011) Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J 30(12):1043–1046CrossRefPubMedPubMedCentral
4.
go back to reference Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104(1 Pt 1):55–60CrossRefPubMed Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104(1 Pt 1):55–60CrossRefPubMed
5.
go back to reference Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, Boppana SB (2006) Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 148(3):332–336CrossRefPubMed Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, Boppana SB (2006) Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 148(3):332–336CrossRefPubMed
6.
go back to reference Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R, Achiron R, Goldberg Y (2008) Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol 31(4):417–420CrossRefPubMed Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R, Achiron R, Goldberg Y (2008) Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol 31(4):417–420CrossRefPubMed
7.
go back to reference Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Oliveira PD, Duarte G, Britt WJ (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(3):297.e1–297.e8CrossRef Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Oliveira PD, Duarte G, Britt WJ (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(3):297.e1–297.e8CrossRef
8.
go back to reference Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. NEngl J Med 344(18):1366–1371CrossRef Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. NEngl J Med 344(18):1366–1371CrossRef
9.
go back to reference Greijer AE, van de Crommert JM, Stevens SJ, Middeldorp JM (1999) Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 37(1):179–188PubMedPubMedCentral Greijer AE, van de Crommert JM, Stevens SJ, Middeldorp JM (1999) Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 37(1):179–188PubMedPubMedCentral
10.
go back to reference Xi Huang JL, Shengxiang G, Tingdong L, Tongming F, Jun Z (2017) Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp 150 antigen. J Virol Methods 240(C):21–25PubMed Xi Huang JL, Shengxiang G, Tingdong L, Tongming F, Jun Z (2017) Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp 150 antigen. J Virol Methods 240(C):21–25PubMed
11.
go back to reference Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, Zhang J, Ng MH, Xia NS (2006) Seroprevalence of hepatitis E virus infection, rural southern People’s Republic of China. Emerg Infect Dis 12(11):1682–1688CrossRefPubMedPubMedCentral Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, Zhang J, Ng MH, Xia NS (2006) Seroprevalence of hepatitis E virus infection, rural southern People’s Republic of China. Emerg Infect Dis 12(11):1682–1688CrossRefPubMedPubMedCentral
12.
go back to reference Li T, Lin H, Yu L, Xue M, Ge S, Zhao Q, Zhang J, Xia N (2014) Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity. J Virol Methods 209:7–14CrossRefPubMed Li T, Lin H, Yu L, Xue M, Ge S, Zhao Q, Zhang J, Xia N (2014) Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity. J Virol Methods 209:7–14CrossRefPubMed
13.
go back to reference Gouma S, Schurink-Van’t Klooster TM, de Melker HE, Kerkhof J, Smits GP, Hahne SJ, van Els CA, Boland GJ, Vossen AC, Goswami PR, Koopmans MP, van Binnendijk RS (2014) Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open forum Infect Dis 1(3):ofu101CrossRefPubMedPubMedCentral Gouma S, Schurink-Van’t Klooster TM, de Melker HE, Kerkhof J, Smits GP, Hahne SJ, van Els CA, Boland GJ, Vossen AC, Goswami PR, Koopmans MP, van Binnendijk RS (2014) Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open forum Infect Dis 1(3):ofu101CrossRefPubMedPubMedCentral
14.
go back to reference Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235(2):288–297CrossRefPubMed Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235(2):288–297CrossRefPubMed
15.
go back to reference Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353(13):1350–1362CrossRefPubMed Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353(13):1350–1362CrossRefPubMed
16.
go back to reference Yinon Y, Farine D, Yudin MH (2010) Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 65(11):736–743CrossRefPubMed Yinon Y, Farine D, Yudin MH (2010) Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 65(11):736–743CrossRefPubMed
17.
go back to reference Zhao P, Ma D, Xue F, Ji C, Wang S, Zhang X, Zhou Y, Yu X (2009) Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population. Arch Virol 154(4):561–564CrossRefPubMed Zhao P, Ma D, Xue F, Ji C, Wang S, Zhang X, Zhou Y, Yu X (2009) Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population. Arch Virol 154(4):561–564CrossRefPubMed
18.
go back to reference Zhang Q, Gao Y, Peng Y, Fu M, Liu YQ, Zhou QJ, Yu J, Zheng XQ (2014) Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China. Virol J 11:123CrossRefPubMedPubMedCentral Zhang Q, Gao Y, Peng Y, Fu M, Liu YQ, Zhou QJ, Yu J, Zheng XQ (2014) Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China. Virol J 11:123CrossRefPubMedPubMedCentral
Metadata
Title
Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population
Authors
T.-d. Li
J.-j. Li
X. Huang
H. Wang
X.-y. Guo
S.-x. Ge
J. Zhang
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2873-8

Other articles of this Issue 5/2017

European Journal of Clinical Microbiology & Infectious Diseases 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine